MARINA GARRISON: Open Payments
NPI 1902207798 · LAWTON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 29 payments from 21 companies in 2025. Trend: 2023 $876 · 2024 $842 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $73 |
| Genmab U.S., Inc. | 2 | $48 |
| Organogenesis Inc. | 1 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| PFIZER INC. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| SOBI, INC | 1 | $25 |
Products named: EPKINLY, SARCLISA, Enhertu, ICLUSIG, AFFINITY, VENCLEXTA, ELREXFIO, NINLARO.
Industry payments across OK — which companies pay providers there.
